全文获取类型
收费全文 | 9994篇 |
免费 | 567篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 333篇 |
妇产科学 | 117篇 |
基础医学 | 1155篇 |
口腔科学 | 444篇 |
临床医学 | 887篇 |
内科学 | 2394篇 |
皮肤病学 | 230篇 |
神经病学 | 796篇 |
特种医学 | 470篇 |
外科学 | 1636篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 535篇 |
眼科学 | 93篇 |
药学 | 458篇 |
中国医学 | 11篇 |
肿瘤学 | 991篇 |
出版年
2024年 | 17篇 |
2023年 | 128篇 |
2022年 | 222篇 |
2021年 | 439篇 |
2020年 | 208篇 |
2019年 | 329篇 |
2018年 | 402篇 |
2017年 | 265篇 |
2016年 | 268篇 |
2015年 | 301篇 |
2014年 | 393篇 |
2013年 | 464篇 |
2012年 | 668篇 |
2011年 | 732篇 |
2010年 | 425篇 |
2009年 | 395篇 |
2008年 | 618篇 |
2007年 | 601篇 |
2006年 | 570篇 |
2005年 | 560篇 |
2004年 | 510篇 |
2003年 | 455篇 |
2002年 | 371篇 |
2001年 | 166篇 |
2000年 | 138篇 |
1999年 | 122篇 |
1998年 | 73篇 |
1997年 | 68篇 |
1996年 | 55篇 |
1995年 | 45篇 |
1994年 | 38篇 |
1993年 | 38篇 |
1992年 | 60篇 |
1991年 | 50篇 |
1990年 | 44篇 |
1989年 | 44篇 |
1988年 | 39篇 |
1987年 | 35篇 |
1986年 | 35篇 |
1985年 | 27篇 |
1984年 | 21篇 |
1983年 | 25篇 |
1982年 | 19篇 |
1980年 | 11篇 |
1979年 | 15篇 |
1977年 | 17篇 |
1975年 | 14篇 |
1974年 | 12篇 |
1973年 | 13篇 |
1968年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
L. Angrisani F. Favretti F. Furbetta L. Busetto S.B. Doldi E. Lattuada M. Paganelli M. Lucchese N. Basso F.D. Capizzi A. Iuppa G. Lesti N. Di Lorenzo C. Giardiello L. Di Cosmo A. Veneziani S. Lacitignola M. Alkilani P. Forestieri M. Toppino A. Gardinazzi F. Puglisi A. Cascardo P. Bernante G. Silecchia B. Marzano A. Adorni V. Borrelli M. Lorenzo 《Surgery for obesity and related diseases》2005,1(3)
24.
Juan Francisco Sánchez Muñoz-Torrero Paloma Barquilla Raul Velasco Maria del Carmen Fernández Capitan Nazaret Pacheco Lucia Vicente Jose Luis Chicón Sara Trejo Jose Zamorano Alicia Lorenzo Hernandez 《European journal of clinical pharmacology》2010,66(12):1257-1264
Objectives
This study was designed to assess the prevalence of adverse drug reactions (ADRs) in the internal medicine wards of two teaching Hospitals, identify the most common ADRs, the principal medications involved, and determine the risk factors implicated in the occurrence of such ADRs. 相似文献25.
Anna Di Landro Lorenzo Marchesi Luigi Naldi Teresio Motta Tullio Cainelli 《Pediatric dermatology》1997,14(6):449-452
Abstract: Hypopigmented mycosis fungoides is a variant of mycosis fungoides characterized by the presence of hypopigmented patches as the sole manifestation of the disease. It has been described aimost always in young black or dark-skinned patients. The only white patient described was a 64-year-oid woman who not oniy had hypopigmented lesions, but also nodular lesions with lymphadenopathy. We describe hypopigmented lesions arising in a white boy 12 years of age, born in northern Italy, without any foreign ancestors. The microscopic alterations, with epidermotropism, the immunoiogic markers, the negativity of T-cell receptor gene rearrangement, and the good response to PUVA therapy correspond to the main findings in black patients with this disease. Long-term follow-up of these patients is important to obtain better knowledge of the natural history of the disorder, Hypopigmented mycosis fungoides must now be included in the differential diagnosis of hypopigmented macular lesions not only in black or dark-skinned patients but also in white patients. 相似文献
26.
Wedge cells during regeneration of juvenile and adult feathers and their role in carving out the branching pattern of barbs 总被引:1,自引:0,他引:1
The present ultrastructural study on regenerating feathers emphasizes the role of supportive cells in determining the branching pattern of barbs. Supportive cells are localized among developing barb and barbule cells, in marginal plates, and underneath the feather sheath, and their differentiative fate, in general, is a form of lipid degeneration. The Latter process determines the carving out of barb branching in both downfeathers and pennaceous feathers. In the latter feathers, some supportive cells (barb vane cells and cylindrical cells of marginal plates) degenerate within each barb ridge leaving separate barbules. Other supportive cells, here termed wedge cells, form columns of cornified material that merge into elongated corneous scaffolds localized among barbs and the rachis. This previously undescribed form of cornification of supportive cells derives from the aggregation of periderm and dense granules present in wedge cells. The latter cells give origin to a corneous material different from feather keratin that may initially sustain the early and soft barbules. After barbules are cornified the supportive cells scaffolds are eventually sloughed as the sheath breaks allowing the new feather to open up and form a planar vane. The corneous material of wedge cells may also contribute to molding of the overlapped nodes of barbule cells that form lateral spines or hooklets in mature barbules. Eventually, the disappearance of wedge cell scaffolding determines the regular spacing of barbs attached to the rachis in order to form a close vane. 相似文献
27.
Francesco Martino Pasquale Pignatelli Eliana Martino Francesco Morrone Roberto Carnevale Serena Di Santo Barbara Buchetti Lorenzo Loffredo Francesco Violi 《Journal of the American College of Cardiology》2007,49(19):1974-1981
OBJECTIVES: The aim of the study was to analyze the behavior of oxidative stress and its interplay with CD40L, a protein that is implicated in atherosclerosis, in hypercholesterolemic children. BACKGROUND: Oxidative stress has been suggested to play a major role in premature atherosclerosis. METHODS: Forty-one children with hypercholesterolemia (mean age 9.28 +/- 0.5 years) and 40 children with normocholesterolemia (mean age 9.02 +/- 0.69 years) were matched for gender and age. Within each group, children were classified as having or not having a family history of cardiovascular disease. Serum levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress, and plasma levels of soluble CD40L (sCD40L) were measured in each child. In a subgroup of children with high (n = 8) or normal (n = 8) levels of serum cholesterol, platelet p38 mitogen-activated protein (MAP) kinase phosphorylation, a protein involved in the activation of nicotinamide adenine dinucleotide phosphate oxidase, was determined. RESULTS: Children with hypercholesterolemia had higher values of 8-OHdG and sCD40L compared with control subjects (0.55 +/- 0.06 ng/ml vs. 0.21 +/- 0.02 ng/ml, p < 0.001 and 0.55 +/- 0.04 ng/ml vs. 0.19 +/- 0.03 ng/ml, p < 0.001, respectively). A significant correlation between 8-OHdG and sCD40L was observed in children with high (r = 0.676, p < 0.001) or normal (r = 0.878, p < 0.001) levels of cholesterol. Children with a family history of cardiovascular disease tended to have higher values of 8-OHdG and sCD40L, but the difference was not significant. Analysis of platelet p38 MAP kinase showed that it was phosphorylated more in children with hypercholesterolemia compared with control subjects (36.8 +/- 5.8 AU vs. 8.0 +/- 4.5 AU, p < 0.001 respectively). CONCLUSIONS: Children with hypercholesterolemia have an early increase of oxidative stress that may be responsible for up-regulation of CD40L and potentially predispose to premature atherosclerosis. 相似文献
28.
Lorenzo Melani Richard Mills David Hassman Robert Lipetz Leslie Lipka Alexandre LeBeaut Ramachandran Suresh Pabak Mukhopadhyay Enrico Veltri 《European heart journal》2003,24(8):717-728
AIMS: To evaluate the efficacy and safety of ezetimibe 10 mg administered with pravastatin in patients with primary hypercholesterolemia. METHODS AND RESULTS: After dietary stabilization, 2-12 week screening/washout period, and 4-week, single-blind, placebo lead-in period, 538 patients with baseline LDL-C > or =3.8 to < or =6.5 mmol/l and TG < or =4.0 mmol/l were randomized to one of eight possible treatments administered daily for 12 weeks: ezetimibe 10mg; pravastatin 10, 20, or 40 mg; ezetimibe 10 mg plus pravastatin 10, 20, or 40 mg; or placebo. The primary efficacy endpoint was percent reduction in LDL-C from baseline to study endpoint for ezetimibe 10 mg plus pravastatin (pooled doses) compared to pravastatin alone (pooled doses) and ezetimibe alone. The combined use of ezetimibe and pravastatin resulted in significant incremental reductions in LDL-C and TG compared to pooled pravastatin alone (p<0.01). Coadministration therapy reduced LDL-C by 34-41%, TG by 21-23%, and increased HDL-C by 7.8-8.4%, depending on the dose of pravastatin. The combined regimen was well tolerated, with a safety profile similar to pravastatin alone and placebo. CONCLUSIONS: When coadministered with pravastatin, ezetimibe provided significant incremental reductions in LDL-C and TG and was well tolerated with a safety profile similar to pravastatin alone. 相似文献
29.
30.
Giovanni Melioli Editta Baldini Maria Cristina Mingari Andrea De Maria Mario Roberto Sertoli Fausto Badellino Pier Luigi Percivale Alessandra Catturich Sergio Bertoglio Dario Civalleri Leonardo Santi Lorenzo Moretta 《International journal of cancer. Journal international du cancer》1989,43(2):231-234
In the course of a phase I trial, in which recombinant IL-2 (rIL-2) was infused intraperitoneally (i.p.) in patients with peritoneal carcinomatosis, we evaluated the effect on "tumor-associated lymphocytes" (TAL) isolated from the ascitic fluid. No major changes in the percentages of cells expressing the CD3, CD4, CD8, Leu-7, OKM1 and WT-31 antigens were detected either in TAL or in peripheral blood lymphocytes (PBL) after 7 days of rIL-2 infusion. In contrast the percentages of TAL (but not PBL) expressing surface IL-2 receptor (Tac), or LAK-1 antigen were sharply increased. Analysis of cytolytic functions showed a potentiation of the lytic activity against natural-killer (NK) sensitive K562 target cells and the de novo appearance of lytic activity against fresh melanoma cells. In one patient IFN-gamma was detected in the ascitic fluid following rIL-2 infusion. T-cell clones derived from the patient were analyzed for the IFN-gamma production. While only approximately 40% of PB-derived control clones produced medium to low amounts of IFN-gamma, all of the TAL-derived clones produced medium to high amounts of the lymphokine. 相似文献